|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,915 KRW | -0.36% |
|
+1.06% | -8.37% |
Icure Pharmaceutical Incorporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 2,147.67 million compared to KRW 1,238.95 million a year ago. Net loss was KRW 31,420.01 million compared to KRW 41,766.44 million a year ago.
Basic loss per share from continuing operations was KRW 837 compared to KRW 1,793 a year ago. Basic loss per share was KRW 837 compared to KRW 1,793 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.37% | 51.99M | |
| -3.33% | 249B | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B |
ICURE PHARMACEUTICAL INCORPORATION 
